1416134-58-1Relevant articles and documents
Synthesis method of ethyl (2S, 5R)-5-[(benzyloxy)amino]-piperidine-2-carboxylate
-
Paragraph 0057-0059, (2019/12/09)
The invention discloses a synthesis method of ethyl (2S, 5R)-5-[(benzyloxy)amino]-piperidine-2-carboxylate. The method comprises the following steps: Boc-L-pyroglutamic acid ethyl ester used as an initial raw material and trimethylsulfoxonium iodide under
B-LACTAMASE INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0089; 0090, (2018/03/07)
The present invention relates to a compound of Formula (I)-(IV) useful as β-lactamase inhibitor, a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, wherein R1, R2, M and ring A have definitions as those in the specification. The present invention further relates to methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and uses of these compounds. For example, the compounds of the present invention can be used as β-lactamase inhibitors, for treatment and/or prophylaxis of diseases caused by bacterial infections, solving drug-resistance problems caused by β-lactamases, especially bacterial drug-resistant diseases caused by type B metallo-β-lactamases.
CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR
-
Paragraph 0106, (2014/09/29)
This disclosure provides compositions containing solid forms of sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, and methods of manufacturing and using these compositions.